Methods of producing mutant polynucleotides

• US 20060019301A1
• Filed: 07/20/2005
• Published: 01/26/2006
• Est. Priority Date: 07/20/2004
• Status: Abandoned Application

• Current Assignee: Novozymes
• Original Assignee: Novozymes, Novozymes A/S (Novozymes)
• Inventors: Hansen, Peter Kamp, Jones, Aubrey, Cherry, Joel, Bjoernvad, Mads Eskelund, Fischer, Amanda
• Application Number:
  US11/186,641
• Publication Number:
  US 20060019301A1
• Time in Patent Office: Days
• US Class Current: 435/6
• CPC Class Codes: C12N 15/102 Mutagenizing nucleic acids
• CPC Class Codes: C12N 15/1082 Preparation or screening gene libraries by chromosomal integration of polynucleotide sequences, HR-, site-specific-recombination, transposons, viral vectors
• CPC Class Codes: C40B 40/08 Libraries containing RNA or DNA which encodes proteins, e.g. gene libraries
• CPC Class Codes: C40B 50/06 Biochemical methods, e.g. using enzymes or whole viable microorganisms

Abstract

The present invention relates to methods of producing mutants of a polynucleotide and to mutant polynucleotides and artificial variants encoded by the mutant polynucleotides.

Claims

1. A method of producing at least one mutant of a polynucleotide, the method comprising the steps of:

(a) isolating a first library of constructs, wherein each construct comprises a first selectable marker, a polynucleotide, an inserted artificial transposon comprising at least two restriction endonuclease recognition sites and a second selectable marker, and a first recombination site flanking the 5′

end of the polynucleotide and a second recombination site flanking the 3′

end of the polynucleotide, wherein the artificial transposon has inserted at one or more random sites within the constructs, and wherein the first library is selected using the first and second selectable markers in a first host cell;

(b) isolating a second library of constructs by introducing the first library of constructs into a vector comprising a third selectable marker and a first recombination site and a second recombination site to facilitate site-specific recombination of the first recombination site flanking the 5′

end of the polynucleotide and the second recombination site flanking the 3′

end of the polynucleotide in the first library of constructs with the first recombination site and the second recombination site of the vector and by selecting the second library of constructs using the second and third selectable markers in a second host cell;

(c) isolating an insertion library containing at least one substitution, deletion, or insertion of at least one nucleotide in each polynucleotide of the second library of constructs by removing all, essentially all, or a portion of the inserted artificial transposon from the second library of constructs through restriction endonuclease digestion of the at least two restriction endonuclease recognition sites leaving at least one substitution, deletion, or insertion of at least one nucleotide in the polynucleotide;

self-ligating the restriction endonuclease digested fragments; and

selecting the insertion library using the third selection marker in a third host cell; and

(d) isolating at least one mutant of the polynucleotide from the insertion library, wherein the isolated mutant comprises at least one substitution, deletion, or insertion of at least one nucleotide in the polynucleotide.

2. The method of claim 1, wherein the polynucleotide encodes a polypeptide.

5. The method of claim 1, wherein the polynucleotide is a control sequence.

7. The method of claim 1, wherein the polynucleotide is an origin of replication.

9. The method of claim 1, wherein the artificial transposon comprises 5′

and 3′

conserved tandem inverted repeats which act as recognition sites for a transposase;

a selectable marker gene located within the transposon sequence; and

at least two restriction endonuclease recognition sites for transposon and selectable marker removal, and for introduction of one or more substitutions, deletions, or insertions, and self-ligation.

10. The method of claim 9, wherein the at least two restriction endonuclease recognition sites comprise one or more inside cutter recognition sequences.

12. The method of claim 9, wherein the at least two restriction endonuclease recognition sites comprise one or more outside cutter recognition sites.

15. A mutant polynucleotide obtained by the method of claim 1.

16. The mutant polynucleotide of claim 15, which encodes a variant of a polypeptide.

19. The mutant polynucleotide of claim 16, wherein the polynucleotide is a control sequence.

21. The mutant polynucleotide of claim 16, wherein the polynucleotide is an origin of replication.

22. A nucleic acid construct comprising the mutant polynucleotide of claim 15 operably linked to one or more control sequences that direct the expression of the mutant polynucleotide in a host cell.

23. A recombinant expression vector comprising the nucleic acid construct of claim 22.

24. A recombinant host cell comprising the nucleic acid construct of claim 22.

25. A method for producing a variant of a polypeptide comprising (a) cultivating the host cell of claim 24 under conditions conducive for production of the variant polypeptide;

and (b) recovering the variant polypeptide.

26. A method for expressing a mutant polynucleotide comprising (a) cultivating the host cell of claim 24 under conditions conducive for expression of the mutant polynucleotide.

3. (canceled)

4. (canceled)

6. (canceled)

8. (canceled)

11. (canceled)

13. (canceled)

14. (canceled)

17. (canceled)

18. (canceled)

20. (canceled)

27. A method of producing at least one polynucleotide encoding at least one variant of a parent polypeptide, the method comprising the steps of:

(a) providing a nucleic acid construct comprising a polynucleotide encoding the parent polypeptide, into which polynucleotide has been inserted a heterologous polynucleotide fragment, wherein said fragment comprises at least two restriction endonuclease recognition sites;

(b) restricting the nucleic acid construct with at least two corresponding restriction endonucleases, if necessary in separate individual steps of restricting, PCR-polishing, and ligating, wherein all or essentially all of the inserted heterologous fragment is excised from the construct and at least one nucleotide triplet is deleted, inserted, or substituted in the encoding polynucleotide in the process, whereby at least one polynucleotide encoding at least one variant of the parent polypeptide is produced.

30. The method of claim 27, wherein the heterologous polynucleotide fragment comprises a transposon.

31. The method of claim 27, wherein the heterologous polynucleotide fragment comprises at least one random or partially random codon triplet ‘

NNN’

.

32. The method of claim 27, wherein the at least two restriction endonuclease recognition sites comprise one or more outside cutter restriction endonuclease recognition site.

33. The method of claim 27, wherein the at least two restriction endonuclease recognition sites comprise one or more outside cutter restriction endonuclease recognition site, and wherein restriction with the one or more corresponding outside cutter endonuclease results in one or more cut in the polynucleotide outside of the inserted heterologous polynucleotide fragment.

34. The method of claim 27, wherein the at least two restriction endonuclease recognition sites comprise two or more different outside cutter restriction endonuclease recognition sites.

36. The method of claim 27, wherein the heterologous polynucleotide fragment comprises a polynucleotide having the sequence shown in SEQ ID NO:

10.

28. (canceled)

29. (canceled)

35. (canceled)

37. A polynucleotide construct comprising a transposon, said transposon comprising one or more outside cutter restriction endonuclease recognition site.

40. The polynucleotide construct of claim 37, wherein at least one of the one or more outside cutter restriction endonuclease recognition site is located so that restriction with at least one corresponding outside cutter restriction endonuclease results in at least one cut in the polynucleotide construct outside of the transposon.

42. The polynucleotide construct of claim 37, wherein the transposon comprises at least one random or partially random codon triplet ‘

NNN’

.

43. The polynucleotide construct of claim 37, wherein the transposon comprises a polynucleotide having the sequence shown in SEQ ID NO:

10.

38. (canceled)

39. (canceled)

41. (canceled)

44. A cell comprising in its genome an integrated heterologous polynucleotide fragment, said fragment comprising one or more outside cutter restriction endonuclease recognition site.

45. The cell of claim 44 wherein the heterologous polynucleotide fragment comprises a transposon, and wherein the one or more outside cutter restriction endonuclease recognition site is comprised in the transposon.

46. The cell of claim 44, wherein the heterologous polynucleotide fragment comprises two or more outside cutter restriction endonuclease recognition sites.

47. The cell of claim 44, wherein the heterologous polynucleotide fragment comprises two or more different outside cutter restriction endonuclease recognition sites.

48. The cell of claim 44, wherein at least one of the one or more outside cutter restriction endonuclease recognition site is located so that restriction with at least one corresponding outside cutter restriction endonuclease results in at least one cut in the genome of the cell outside of the integrated heterologous polynucleotide fragment.

50. The cell of claim 44, wherein the heterologous polynucleotide fragment comprises at least one random or partially random codon triplet ‘

NNN’

.

51. The cell of claim 44, wherein the heterologous polynucleotide fragment comprises a polynucleotide having the sequence shown in SEQ ID NO:

10.

49. (canceled)